Immunetrics is a bio-simulation company on the cutting edge of in silico modeling. The Company's modeling technology provides critical information to accelerate and improve drug discovery and development.

The power of predictive models is obvious in many industries, from aircraft and automotive design to supply-chain optimization. Working with pharmaceutical clients and global thought leaders, Immunetrics brings the power of computational modeling to biomarker development, preclinical experiment design, lead selection, and clinical trial design. This reduces risk while speeding the path to approval.

This is not statistical modeling. Immunetrics builds bottom-up predictive models based on biological pathways spanning the molecular, cellular, organ, organism, and population scales. We collaborate with our customers to provide proprietary models for their exclusive use. Please read more about our technology or contact us today for more information.

The problems we address are all too familiar in the pharmaceutical and biotech industries. Efficacy signals that vanish in larger studies. Confirmatory trials that fail to replicate. Labels so narrow they miss the market. And worst of all, late-stage or post-approval safety surprises. These problems are born in the gap between models and reality, between pilot study and proof of concept. If only the data could provide true predictive power between every stage of discovery and development.

Biosimulation technology from Immunetrics Inc. translates data between model systems and between development stages. Put simply, we build predictive computer models based on biology. The inputs are customer data and the outputs are real endpoints, whether the goal is power calculation, dosage selection, exclusion criteria, PK/PD modeling, biomarker identification, or any other factor in clinical study design.

Current Updates: